Myeloma UK – current focus and future directions
Indications for the use of brentuximab vedotin in relapsed/refractory Hodgkin lymphoma
What makes the British Society for Haematology (BSH) Annual Scientific Meeting unique?
An overview of the current treatment landscape of non-Hodgkin lymphoma
EuroBloodNet European Reference Network - when will it be in place and why is collaboration crucial?
Joan Lluis Vives-Corrons et al.